Article Versions Notes

Rieth JM, Swami U, Mott SL, Zanaty M, Henry MD, Bossler AD, Greenlee JD, Zakharia Y, Vanneste M, Jennings B, et al. Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy. Cancers. 2021; 13(7):1489. https://doi.org/10.3390/cancers13071489

Rieth, John M., Umang Swami, Sarah L. Mott, Mario Zanaty, Michael D. Henry, Aaron D. Bossler, Jeremy D. Greenlee, Yousef Zakharia, Marion Vanneste, Brooke Jennings, and et al. 2021. "Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy" Cancers 13, no. 7: 1489. https://doi.org/10.3390/cancers13071489

Rieth, J. M., Swami, U., Mott, S. L., Zanaty, M., Henry, M. D., Bossler, A. D., Greenlee, J. D., Zakharia, Y., Vanneste, M., Jennings, B., & Milhem, M. M. (2021). Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy. Cancers, 13(7), 1489. https://doi.org/10.3390/cancers13071489